Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
30 hedge funds and large institutions have $26.3M invested in Applied Therapeutics in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
567% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 3
131% more funds holding
Funds holding: 13 → 30 (+17)
45% more capital invested
Capital invested by funds: $18.1M → $26.3M (+$8.23M)
1.17% more ownership
Funds ownership: 12.88% → 14.05% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$783K |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$673K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$330K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$228K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$152K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$283K |
| 2 |
Goldman Sachs
New York
|
-$203K |
| 3 |
BlackRock
New York
|
-$57.9K |
| 4 |
Alkeon Capital Management
New York
|
-$7.18K |
| 5 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$7K |
APLT Hedge Fund Activity: Q3 2019 in Review
30 of the 4,575 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q3 2019, worth a combined $26.3M — up 45% from $18.1M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new APLT positions and 3 closed out — a net gain of 17 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $783K. The largest seller was Millennium Management, cutting an estimated $283K.
- 30 institutional investors held Applied Therapeutics (APLT) as of Q3 2019, up from 13 in Q2 2019.
- Funds reported $26.3M of Applied Therapeutics stock for Q3 2019, up 45% quarter-over-quarter.
- 20 funds opened new Applied Therapeutics positions in Q3 2019 and 3 closed out, a net change of +17 holders.
- The largest Applied Therapeutics buyer in Q3 2019 was Acuta Capital Partners, an estimated $783K added.
- The largest Applied Therapeutics seller in Q3 2019 was Millennium Management, an estimated $283K sold.
Based on aggregated 13F filings for Q3 2019.